PITTSBURGH, May 17 Issues on the forefront of HIV prevention research will be taking center stage at the International Microbicides Conference (M2010) at the David L. Lawrence Convention Center in Pittsburgh May 22-25. M2010 will be a gathering of leading investigators, clinicians, policy makers, community advocates and experts in global health who are working in all facets of HIV prevention and in all parts of the world. Nearly 1,000 participants from 47 countries will be attending.
The meeting includes discussions of new research developments on a number of different HIV prevention strategies, including microbicides and pre-exposure prophylaxis (PrEP). Microbicides are substances designed to be applied topically on the inside of the rectum or vagina to prevent the acquisition of HIV, whereas oral PrEP is an approach involving the use of antiretroviral drugs by HIV-negative people to reduce their risk of acquiring HIV.
An on-site press room for registered media will be located in Room 309 of the Convention Center. Hours of operation will be 7 a.m. to 7 p.m. (ET), Saturday, May 22 through Tuesday, May 25. Press room staff can be reached during this time at +1 (412) 325-6063/6064. Press briefings will be held each day (please the schedule below). Journalists unable to attend in-person may participate via domestic and international teleconference.
The schedule of press briefings and topics to be discussed are listed below:
SUNDAY, May 23
A Time of Greater Risk: Protecting Against HIV During Pregnancy
Young women of reproductive-age are among those at greatest risk of acquiring HIV. Several studies have suggested that during pregnancy women are even more susceptible to infection. Women need a method to protect themselves all the time, including when they are pregnant. Researchers will report results of the first clinical trial to evaluate the safety of a vaginal microbicide in pregnan
|Contact: Lisa Rossi|
Microbicides 2010 (International Conference on Microbicides)